FAM174B and cancer: Comprehensive evaluation of the cancer-immunity cycle demonstrated enhanced immune activation in tumors with reduced FAM174B expression, evidenced by elevated scores in critical immune processes such as lymphocyte recruitment and tumor cell elimination.